ArticleMolecular therapy oncolytics2022

Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine.

Soledad Palameta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.